Next Investors logo grey

Creso Pharma delivers third order of Ritual Green brand


Published 27-OCT-2020 10:47 A.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Creso Pharma Limited’s (ASX: CPH; FRA: 1X8) wholly-owned Canadian subsidiary, Mernova Medicinal Inc. a licensed producer in Nova Scotia, has received and successfully delivered its third purchase order (PO) from the Nova Scotia Liquor Corporation (NSLC).

The third PO is for 20 cases of Mernova’s ‘Mimosa’ (15-20% THC, less than 1% CBD) strain which is Mernova’s value brand now launched under the Ritual Green brand.

The introduction of the strain will allow Mernova to pursue a much larger addressable market, targeting consumers who are seeking premium quality at a more reasonable price-point.

This marks the third PO received from the NSLC in the last four weeks, with the two previous orders for the company’s premium strains, HPG13 (20-25% THC, < 1% CBD), and Lemon Haze (20-25% THC, < 1% CBD) continuing to sell well.

Creso is very confident that it will continue to receive purchase orders from the NSLC of its Mimosa and premium quality strains, allowing the company to build on the C$320,000 in revenue it has generated in the last month from the NSLC.

3a - CPH.PNG

Mernova benefiting from e-commerce sales

Mernova’s Ritual Green products are sold through NSLC stores and e-commerce platform.

The additional purchase order serves as further confirmation of the success of the Ritual Green brand of high-quality cannabis products in the rapidly growing Canadian retail recreational market.

Mernova continues to make significant inroads into the Nova Scotia recreational market with its diverse products offering premium quality at a competitive price point.

Commenting on recent sales developments and the prospect of maintaining this momentum, Mernova managing director Jack Yu said, “Securing this additional purchase order from the NSLC is a significant achievement, and further validates the success of the recent Ritual Green product launch.

“Our products continue to garner very positive feedback from customers and we are confident that the Mimosa strain will unlock a large portion of the market that we can capitalise on in the near term.

“We look forward to updating shareholders on progress in Nova Scotia, additional strain launches under the Ritual Green product range, and further orders to be finalised in the near term.”

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.